John Overdeck’s BioNTech BNTX Stock Holding History

John Overdeck’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.2M	Buy	292,614 +126,435	+76%	+$11.9M	0.02%	863
2026 Q1	$14.8M	Buy	166,179 +57,921	+54%	+$5.95M	0.01%	1148
2025 Q4	$10.3M	Buy	+108,258	New	+$10.9M	0.01%	1103
2024 Q3	–	Sell	-11,653	Closed	-$936K	–	3125
2024 Q2	$936K	Buy	+11,653	New	+$1.07M	﹤0.01%	2022
2024 Q1	–	Sell	-2,200	Closed	-$232K	–	3045
2023 Q4	$232K	Sell	2,200 -6,100	-73%	-$615K	﹤0.01%	2776
2023 Q3	$902K	Hold	8,300	–	–	﹤0.01%	1994
2023 Q2	$896K	Buy	+8,300	New	+$934K	﹤0.01%	1999
2023 Q1	–	Sell	-9,300	Closed	-$1.4M	–	2972
2022 Q4	$1.4M	Buy	+9,300	New	+$1.43M	﹤0.01%	1526
2021 Q4	–	Sell	-57,831	Closed	-$15.8M	–	4303
2021 Q3	$15.8M	Sell	57,831 -220,492	-79%	-$70.1M	0.04%	562
2021 Q2	$62.3M	Buy	+278,323	New	+$52.5M	0.14%	169
2021 Q1	–	Sell	-121,635	Closed	-$9.92M	–	3829
2020 Q4	$9.92M	Buy	+121,635	New	+$11.9M	0.03%	590

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

John Overdeck's BNTX Position: Q2 2026 in Review

John Overdeck increased its BioNTech (BNTX) stake by 76% in Q2 2026, buying an estimated $11.9M and bringing the position to 292,614 shares worth $27.2M. The position accounts for 0.02% of the portfolio, ranked #863.

John Overdeck first reported a position in BNTX in Q4 2020 and has held it in 11 quarters since. The position peaked at $62.3M in Q2 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

John Overdeck held 292,614 shares of BioNTech worth $27.2M as of Q2 2026.
John Overdeck bought 126,435 BioNTech shares in Q2 2026, an estimated $11.9M.
BioNTech made up 0.02% of John Overdeck's portfolio in Q2 2026, its #863 holding.
John Overdeck first reported a position in BioNTech in Q4 2020 and has held it in 11 quarters since.
John Overdeck's BioNTech position peaked at $62.3M in Q2 2021.
281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.